Trial intelligence / Profile preview

Clozapine vs. Olanzapine in Refractory Schizophrenia

NCT00169065Phase 4Completed

Sponsor
Harvard Medical School
Start
Aug 1998
Primary completion
Jun 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of olanzapine in schizophrenia, sponsored by Harvard Medical School. Started Aug 1998; status: completed.

02

Drugs

olanzapine
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00169065.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00169065.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call